Covid-19 roundup: 60 mil­lion J&J dos­es from Emer­gent to be tossed; EMA up­dates As­traZeneca vac­cine warn­ings

Af­ter a two-month hold on mil­lions of dos­es of the J&J vac­cine, the FDA will an­nounce that it is re­leas­ing 10 mil­lion dos­es and trash­ing 60 mil­lion that were made at a trou­bled Bal­ti­more plant, The New York Times scooped on Fri­day morn­ing.

Emer­gent BioSo­lu­tions re­port­ed that the dos­es were con­t­a­m­i­nat­ed af­ter drug ma­te­r­i­al in­tend­ed for the As­traZeneca vac­cine came in close con­tact with me­dia pre­pared for a J&J run. As a re­sult, the dos­es were held from dis­tri­b­u­tion, caus­ing a shake­up in ear­ly avail­abil­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.